ENTRY       D00533                      Drug
NAME        Oxcarbazepine (JAN/USP/INN);
            Oxtellar (TN);
            Trileptal (TN)
PRODUCT     OXTELLAR XR (Supernus Pharmaceuticals)
            TRILEPTAL (Novartis Pharmaceuticals Corporation)
  GENERIC   OXCARBAZEPINE (Advagen Pharma Limited)
            OXCARBAZEPINE (Advagen Pharma)
            OXCARBAZEPINE (American Health Packaging)
            OXCARBAZEPINE (American Health Packaging)
            OXCARBAZEPINE (Amneal Pharmaceuticals LLC)
            OXCARBAZEPINE (AvPAK)
            OXCARBAZEPINE (AvPAK)
            OXCARBAZEPINE (AvPAK)
            OXCARBAZEPINE (Bionpharma)
            OXCARBAZEPINE (Breckenridge Pharmaceutical)
            OXCARBAZEPINE (Bryant Ranch Prepack)
            OXCARBAZEPINE (Bryant Ranch Prepack)
            OXCARBAZEPINE (Bryant Ranch Prepack)
            OXCARBAZEPINE (Bryant Ranch Prepack)
            OXCARBAZEPINE (Bryant Ranch Prepack)
            OXCARBAZEPINE (Bryant Ranch Prepack)
            OXCARBAZEPINE (Bryant Ranch Prepack)
            OXCARBAZEPINE (Bryant Ranch Prepack)
            OXCARBAZEPINE (Bryant Ranch Prepack)
            OXCARBAZEPINE (Camber Pharmaceuticals)
            OXCARBAZEPINE (Cardinal Health 107)
            OXCARBAZEPINE (Cardinal Health 107)
            OXCARBAZEPINE (Cardinal Health 107)
            OXCARBAZEPINE (DirectRx)
            OXCARBAZEPINE (EPIC PHARMA)
            OXCARBAZEPINE (Glasshouse Pharmaceuticals Limited Canada)
            OXCARBAZEPINE (Glenmark Pharmaceuticals)
            OXCARBAZEPINE (Golden State Medical Supply)
            OXCARBAZEPINE (Hikma Pharmaceuticals USA)
            OXCARBAZEPINE (Major Pharmaceuticals)
            OXCARBAZEPINE (NCS HealthCare of KY)
            OXCARBAZEPINE (NCS HealthCare of KY)
            OXCARBAZEPINE (NuCare Pharmaceuticals)
            OXCARBAZEPINE (Precision Dose)
            OXCARBAZEPINE (Preferred Pharmaceuticals)
            OXCARBAZEPINE (Proficient Rx LP)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (REMEDYREPACK)
            OXCARBAZEPINE (Sandoz)
            OXCARBAZEPINE (Sun Pharmaceutical Industries)
            OXCARBAZEPINE (Taro Pharmaceuticals U.S.A.)
FORMULA     C15H12N2O2
EXACT_MASS  252.0899
MOL_WEIGHT  252.268
CLASS       Neuropsychiatric agent
             DG03199  Antiepileptic agent
              DG02034  Carboxamide antiepileptic
            Metabolizing enzyme inhibitor
             DG01933  CYP2C19 inhibitor
            Metabolizing enzyme inducer
             DG02853  CYP3A/CYP3A4 inducer
REMARK      Same as: C07492
            ATC code: N03AF02
            Product: D00533<US>
EFFICACY    Anticonvulsant, Antiepileptic
COMMENT     Carboxamide derivative
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04728(6323)  Dopaminergic synapse
INTERACTION CYP induction: CYP3A [HSA:1576 1577 1551]
            CYP inhibition: CYP2C19 [HSA:1557]
STR_MAP     map07033  Anticonvulsants
OTHER_MAP   map00982  Drug metabolism - cytochrome P450
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AF Carboxamide derivatives
                 N03AF02 Oxcarbazepine
                  D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Sodium Channel Agents
               Oxcarbazepine
                D00533  Oxcarbazepine (JAN/USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02034  Carboxamide antiepileptic
                D00533  Oxcarbazepine
             Metabolizing enzyme inhibitor
              DG01933  CYP2C19 inhibitor
               D00533  Oxcarbazepine
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               D00533  Oxcarbazepine
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D00533  Oxcarbazepine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
                SCN2A
                 D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
                SCN3A
                 D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
                SCN4A
                 D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
                SCN5A
                 D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
                SCN8A
                 D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
                SCN9A
                 D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
                SCN10A
                 D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
                SCN11A
                 D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00533
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00533
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00533
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00533
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00533
DBLINKS     CAS: 28721-07-5
            PubChem: 7847599
            ChEBI: 7824
            LigandBox: D00533
            NIKKAJI: J21.258J
ATOM        19
            1   C5x C    18.8052  -13.4873
            2   C8y C    17.9608  -12.3747
            3   C8y C    18.2969  -11.0142
            4   N1y N    19.5614  -10.4345
            5   C1x C    20.2148  -13.5126
            6   C8y C    20.8183  -11.0585
            7   C8y C    21.1056  -12.4310
            8   C8x C    17.2870  -10.0431
            9   C8x C    15.9414  -10.4323
            10  C8x C    15.6053  -11.7928
            11  C8x C    16.6151  -12.7636
            12  C8x C    22.4404  -12.8693
            13  C8x C    23.4875  -11.9323
            14  C8x C    23.2004  -10.5598
            15  C8x C    21.8653  -10.1215
            16  C5a C    19.5131   -9.0558
            17  N1a N    20.7404   -8.3728
            18  O5x O    18.0836  -14.6869
            19  O5a O    18.2961   -8.3686
BOND        21
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13    7  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    6  15 2
            18    4  16 1
            19   16  17 1
            20    1  18 2
            21   16  19 2
///
